SHR-7367
- Generic Name
- SHR-7367
A Trial of SHR-7367 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 182
- Registration Number
- NCT05740202
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath